• OncoC4 and AcroImmune Announce Merger | Morningstar

    Source: Buzz FX / 25 Sep 2024 06:57:20   America/Chicago


    [GlobeNewswire](/news/globe-newswire) OncoC4 and AcroImmune Announce Merger Merger expands OncoC4’s wholly owned immunotherapy pipeline and establishes in-house clinical manufacturing capabilities Adds IND-ready AI-081, a PD-1/VEGF bispecif
    Read more...
Share on,